39 results
8-K
EX-3.1
MYMD
MyMD Pharmaceuticals Inc
23 May 24
Material Modifications to Rights of Security Holders
4:05pm
8-K
EX-3.2
MYMD
MyMD Pharmaceuticals Inc
23 May 24
Material Modifications to Rights of Security Holders
4:05pm
8-K
EX-3.2
MYMD
MyMD Pharmaceuticals Inc
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
EX-3.1
MYMD
MyMD Pharmaceuticals Inc
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
EX-3.3
MYMD
MyMD Pharmaceuticals Inc
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
EX-3.1
z16w4e01kp8h m4d
8 Apr 24
Entry into a Material Definitive Agreement
4:49pm
8-K/A
EX-3.3
y4bt8bcee kqf
26 Mar 24
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
EX-3.1
kq3hm
7 Mar 24
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-3.2
c0j 9anoi0
7 Mar 24
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-3.1
cl8o7r mux
13 Feb 24
MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing
4:57pm
8-K
EX-3.1
fgzgn3sb4h 37
21 Feb 23
MyMD Announces $15 Million Offering with Existing Investors
9:00am
8-K
EX-3.2
69r 8ir6rm6cc
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
8-K
EX-3.1
u4ba kftm77agc9n
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
8-K
EX-3.3
ba7o1g5l5 biarx
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
8-K
EX-3.1
mygwigf
9 Sep 20
Entry into a Material Definitive Agreement
4:50pm